Fatma Humeyra Yerlikaya
Overview
Explore the profile of Fatma Humeyra Yerlikaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yerlikaya F, Onmaz D, Selvi Y, Topkafa M, Sivrikaya A, Kaya S, et al.
J Psychiatr Res
. 2025 Feb;
183:25-30.
PMID: 39923354
Background: It is becoming increasingly clear that the relationship between sleep disturbance and gut microbiota metabolites is of great importance. Aims: This study aimed to examine the changes in microbiota...
2.
Turkmen K, Baloglu I, Aykut T, Demir S, Altin E, Akguzel Z, et al.
Saudi J Kidney Dis Transpl
. 2024 Jul;
34(5):406-415.
PMID: 38995299
Fabry disease (FD) is associated with inflammation, proteinuria, and chronic kidney disease. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) plays an important role in inflammation in diabetic nephropathy and...
3.
Karatoprak S, Acikel S, Akyildiz A, Coskun F, Yerlikaya F
Int J Dev Disabil
. 2024 Jul;
70(4):677-683.
PMID: 38983482
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, the etiology of which has not been clearly determined yet. There is increasing evidence that synaptic and dendritic changes are involved in...
4.
Can M, Kocabas M, Yarar Z, Burgucu H, Karakose M, Yerlikaya F, et al.
Arch Endocrinol Metab
. 2023 May;
67(4):e000622.
PMID: 37252704
Objective: In this study, we aimed to evaluate subclinical atherosclerosis in patients with obesity who had cardiovascular disease risk indicators such as arterial stiffness, which is evaluated using pulse wave...
5.
Abusoglu S, Onmaz D, Abusoglu G, Yerlikaya F, Unlu A
J Mass Spectrom Adv Clin Lab
. 2023 Apr;
28:114-121.
PMID: 37113385
Objectives: Recent studies have shown that derangements in kynurenine pathway metabolite levels are associated with various pathologies such as neurodegenerative diseases, schizophrenia, depression, bipolar disorder, rheumatoid arthritis, and cancer. Therefore,...
6.
Calis B, Yerlikaya F, Ataseven A, Temiz S, Onmaz D
Indian J Dermatol
. 2023 Mar;
67(6):657-661.
PMID: 36998860
Background: Acne vulgaris is a common chronic inflammatory skin disease in adolescents and oxidative stress plays an important role in acne pathology. However, the pathology of acne has not yet...
7.
Onmaz D, Tezcan D, Abusoglu S, Sak F, Yerlikaya F, Yilmaz S, et al.
Clin Biochem
. 2023 Jan;
114:1-10.
PMID: 36681140
Objectives: Primary Sjögren's syndrome (pSS) is an autoinflammatory disease characterized by inflammation of the exocrine glands. Elevated inflammation causes an increase in kynurenine pathway (KP) metabolite levels by activating indoleamine...
8.
Demirbas S, Yerlikaya F, Yosunkaya S, Can U, Celalettin K
Medicine (Baltimore)
. 2023 Jan;
101(52):e32471.
PMID: 36595996
Background: Progranulin (PGRN), endothelial cell-specific molecule-1, clusterin (CLU), and human epididymis protein 4 (HE-4) are novel proteins reported to have diagnostic and prognostic potential in lung cancer. Here, we aimed...
9.
Acikel S, Artik A, Hosoglu E, Yerlikaya F
Psychiatr Danub
. 2022 Dec;
34(4):677-681.
PMID: 36548880
Background: Apelin-13 have potential effect on mood because of high expression in the hypothalamus. In this study, we aimed to investigate the serum apelin-13 levels among adolescents with major depressive...
10.
Kocabas M, Alsancak Y, Can M, Cordan I, Burgucu H, Karakose M, et al.
Turk J Med Sci
. 2022 Nov;
52(4):1033-1040.
PMID: 36326370
Background: Data on the presence and extent of cardiovascular disease (CVD) risk in primary hyperparathyroidism (PHPT) are conflicting. In our study, we aimed to investigate the increased CVD risk in...